Pasithea Therapeutics announces annual shareholder meeting

Reuters2026/08/07 21:19

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Pasithea Therapeutics will hold its annual stockholders meeting in a virtual format on Sept. 9, 2026.
Stockholders will vote on the election of two Class III director nominees, including Tiago Reis Marques and Lawrence Steinman.
Meeting agenda also includes ratifying CBIZ CPAs as independent auditor for the fiscal year ending Dec. 31, 2026.
Investors will also consider a reverse stock split, with the board authorized to set a ratio from 1-for-2 to 1-for-20.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pasithea Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-086799), on August 07, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Pasithea Therapeutics announces annual shareholder meeting

You may also like

Crypto prices